Lv1
38 积分 2026-05-25 加入
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
13小时前
已完结
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
13小时前
已完结
Non-invasive profiling of the tumour microenvironment with spatial ecotypes
2个月前
已完结
Mechanism of Tumor-Platelet Communications in Cancer
3个月前
已完结
皖公网安备34019202002308
